Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
4/10/2026
CDE Seeks Comments on New Technical Guideline for Staged Manufacturing...
4/10/2026
China Unveils Sweeping Measures to Accelerate Tiered Healthcare System...
4/10/2026
Xuanzhu Expands Global Oncology Reach With Boston Oncology Licensing D...
4/10/2026
DualityBio Wins China BLA Acceptance for HER2 Breast Cancer ADC, Movin...
4/10/2026
IMPACT Thera Secures $5M Milestone as PARP1-Selective IMP1734 Advances...
4/10/2026
Oricell Raises Over $110M Pre-IPO to Advance Global Solid Tumor CAR-T ...
4/9/2026
CDE Releases New Clinical Evaluation Guideline for IND Applications to...
4/9/2026
CDE Issues New Clinical Evaluation Guideline for Drug Marketing Applic...
4/9/2026
Syneron Emerges as a Macrocycle Powerhouse as Funding and AZ Deal Fuel...
4/9/2026
Luye Advances Next-Gen Schizophrenia Candidate LY03020 Into Phase II i...
4/9/2026
Over Half of China-Listed Drugmakers Grow 2025 Profit as Innovation an...
4/9/2026
Gan & Lee Out-Licenses Bi-Weekly GLP-1 Candidate Bofanglutide to JW Ph...
4/9/2026
GSK Wins China Approval for Exdensur in Chronic Rhinosinusitis With Na...
4/9/2026
NMPA Clears BioGenesis's Recombinant Human Hyaluronidase
4/9/2026
Everest Medicines to Acquire Hasten's Asia-Pacific Platform in $250M ...
4/8/2026
NMPA Adopts ICH M14 Guideline, Expanding China's Regulatory Framework ...
4/8/2026
NMPA Adopts ICH Q8, Q9 and Q10 Q&A (R5)
4/8/2026
Merck and Zhifei Shift to Demand-Based China Vaccine Supply Model as G...
4/7/2026
Aidea Wins China IND Clearance for Long-Acting HIV PrEP Candidate ACC0...
4/7/2026
Bayer Deepens China Innovation Push as Pharma Division Targets 30% Mar...
4/7/2026
Kelun-Biotech and HBM's Atopic Dermatitis Bispecific Revealed as TSLP/...
4/7/2026
Chengdu NRT Closes CNY 1B Series E to Accelerate Radiopharma Commercia...
4/7/2026
Henlius Wins China IND Approval for HLX319, Advancing SC HER2 Breast C...
4/7/2026
Adagene, Incyte Launch Clinical Collaboration to Advance Novel MSS Col...
4/3/2026
NMPA Suspends Import, Sale and Use of Cadila's Amlodipine Besylate API...
4/3/2026
Hengrui Unveils Promising Phase 1 Data for FIC Dual-Target Psoriasis A...
4/3/2026
Recent Executive Moves
4/3/2026
Myeloid Cure Biotech Secures Over CNY 150M in Series A to Advance Mac...
4/3/2026
XellSmart Secures CNY 500M+ to Accelerate Parkinson's, ALS and SCI iPS...
4/3/2026
Yifan/Evive Expands Ryzneuta Europe Footprint With France Licensing De...
Page:
1
/
61
Total number of articles:
1828
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit